C
Cue Health Inc
OTC:HLTHQ
Cue Health Inc
OTC:HLTHQ
Price:
0
USD
Market Cap:
$0
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cue Health Inc
OTC:HLTHQ
|
US |
|
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
|
CN |
|
Xbrane Biopharma AB
STO:XBRANE
|
SE |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
US |
Income Statement
Earnings Waterfall
Cue Health Inc
Cue Health Inc
Income Statement
Cue Health Inc
Cue Health Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
10
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Revenue |
618
N/A
|
596
-4%
|
683
+15%
|
529
-23%
|
484
-9%
|
329
-32%
|
251
-24%
|
199
-21%
|
71
-64%
|
56
-21%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(277)
|
(278)
|
(380)
|
(342)
|
(330)
|
(283)
|
(211)
|
(182)
|
(127)
|
(104)
|
|
| Gross Profit |
342
N/A
|
318
-7%
|
303
-4%
|
187
-38%
|
154
-18%
|
46
-70%
|
40
-12%
|
17
-59%
|
(56)
N/A
|
(47)
+16%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(151)
|
(204)
|
(290)
|
(329)
|
(357)
|
(340)
|
(313)
|
(287)
|
(241)
|
(206)
|
|
| Selling, General & Administrative |
(109)
|
(145)
|
(187)
|
(192)
|
(186)
|
(153)
|
(133)
|
(112)
|
(90)
|
(70)
|
|
| Research & Development |
(43)
|
(60)
|
(104)
|
(137)
|
(172)
|
(187)
|
(180)
|
(174)
|
(151)
|
(135)
|
|
| Operating Income |
190
N/A
|
114
-40%
|
13
-89%
|
(142)
N/A
|
(204)
-44%
|
(295)
-45%
|
(273)
+7%
|
(270)
+1%
|
(297)
-10%
|
(253)
+15%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(69)
|
(38)
|
(38)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
5
|
6
|
|
| Non-Reccuring Items |
(2)
|
0
|
(2)
|
(2)
|
(2)
|
(10)
|
(15)
|
6
|
(77)
|
(75)
|
|
| Total Other Income |
0
|
1
|
1
|
1
|
3
|
4
|
6
|
8
|
0
|
(2)
|
|
| Pre-Tax Income |
119
N/A
|
76
-36%
|
(27)
N/A
|
(143)
-439%
|
(204)
-42%
|
(301)
-48%
|
(282)
+6%
|
(257)
+9%
|
(369)
-43%
|
(324)
+12%
|
|
| Net Income | |||||||||||
| Tax Provision |
(33)
|
(20)
|
(16)
|
15
|
10
|
10
|
6
|
1
|
(5)
|
0
|
|
| Income from Continuing Operations |
86
|
56
|
(43)
|
(128)
|
(194)
|
(291)
|
(276)
|
(257)
|
(373)
|
(329)
|
|
| Net Income (Common) |
86
N/A
|
56
-35%
|
(43)
N/A
|
(128)
-200%
|
(194)
-51%
|
(291)
-50%
|
(276)
+5%
|
(257)
+7%
|
(373)
-46%
|
(329)
+12%
|
|
| EPS (Diluted) |
0.59
N/A
|
0.38
-36%
|
-0.29
N/A
|
-0.87
-200%
|
-1.31
-51%
|
-1.92
-47%
|
-1.83
+5%
|
-1.69
+8%
|
-2.44
-44%
|
-2.07
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
